Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q3 2020 Results Earnings Conference Call November 5, 2020 8:00 AM ET Company Participants Stephanie Carrington - IR, Westwicke Keith Kendall - President and Chief Executive Officer John Maxwell - SVP and Chief Financial Officer Dan Barber - SVP and Chief Operating Officer Ken Marshall - SVP and Chief Commercial Officer Conference Call Participants Gary Nachman - BMO Capital Markets Andreas Argyrides - Wedbush Thomas Flaten - Lake Street Capital Operator Ladies and ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number: 001-38599 Aquestive Therapeutics, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 30 Technolog ...

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q2 2020 Results Earnings Conference Call August 5, 2020 8:00 AM ET Company Participants Stephanie Carrington - IR, Westwicke Keith Kendall - President and Chief Executive Officer John Maxwell - SVP and Chief Financial Officer Daniel Barber - SVP and Chief Operating Officer Ken Marshall - SVP and Chief Commercial Officer Conference Call Participants Rafay Sardar - BMO Capital Markets Shveta Dighe - Wedbush Securities, Inc. Jason Butler - JMP Securities Thomas Flaten ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number: 001-38599 Aquestive Therapeutics, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 30 Technology Dri ...

Aquestive Therapeutics, Inc. (HEI) Q1 2020 Earnings Conference Call May 7, 2020 8:00 AM ET Company Participants Stephanie Carrington - Westwicke, IR Keith Kendall - CEO, President and Director John Maxwell - CFO Daniel Barber - COO Ken Marshall - CCO Conference Call Participants Rafay Sardar - BMO Capital Markets Randall Stanicky - RBC Capital Markets Liana Moussatos - Wedbush Securities Jason Butler - JMP Securities Thomas Flaten - Lake Street Capital Blair Cohen - H.C. Wainwright Operator Good morning, an ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to Commission File Number: 001-38599 Aquestive Therapeutics, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 30 Technology Drive, W ...

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q4 2019 Earnings Conference Call March 12, 2020 8:00 AM ET Company Participants Stephanie Carrington - Westwicke Investor Relations Keith Kendall - Chief Executive Officer John Maxwell - Chief Financial Officer Conference Call Participants Gary Nachman - BMO Capital Markets Dan Busby - RBC Capital Markets Roy Buchanan - JMP Securities Liana Moussatos - Wedbush Securities Thomas Flaten - Lake Street Capital Markets Edward White - H.C. Wainwright Operator Good mornin ...